NEW YORK (GenomeWeb News) – Mitochondrial DNA-based test developer Mitomics today announced a realignment of its product development operations, resulting in the elimination of eight jobs.
Chief Laboratory Officer Jennifer Creed will also now lead end-to-end product development for the company based in Thunder Bay, Ontario.
In a statement, Mitomics President and CEO Robert Poulter said that the firm "continues to face tremendous opportunity and potential for growth in the diagnostics arena."